Nussbaum Ran — insider trades

Stock trades Nussbaum Ran reported on SEC Form 4 at KROS Keros Therapeutics, Inc., LBRX LB PHARMACEUTICALS INC.

• Oct 15, 2025: sold 4,787,331 shares of KROS Keros Therapeutics, Inc. ($85.0M)
• Sep 12, 2025: bought 1,000,000 shares of LBRX LB PHARMACEUTICALS INC ($15.0M)